Anticonvulsants for Neuropathic Pain Market: Industry Survey and Outlook 2025
Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most popular treatment mechanisms and the pathogenesis of neuropathic pain remain somewhat unclear.
Owing to the several similarities between the pathophysiological symptoms observed in neuropathic pain models and in some epilepsy models, anticonvulsants are finding increased usage in the symptomatic management of neuropathic pain conditions. Carbamazepine, the world’s first anticonvulsant examined in clinical trials, continues to remain one of the key choices of healthcare practitioners for neuropathic pain conditions. Apart from carbamazepine, a number of new anticonvulsants in the market or in high quality clinical trials represent a new era in the treatment of neuropathic pain.
Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=32
The overall role of anticonvulsants in the treatment of neuropathic pain continues to evolve. Further advances in the overall understanding of the mechanisms of neuropathic pain conditions and well-designed clinical trials are expected to further improve the opportunities to make anticonvulsants an established course of action in the treatment of neuropathic pain. This report examines the current state of development of the global market for anticonvulsants, with applications in the treatment of neuropathic pain at the center of focus. Recent developments and future scope of development of the market are also analyzed.
Global Anticonvulsants for Neuropathic Pain Market
Neurapthic pain (NP) is a severe pain associated with a number of diseases such as cancer, diabetes, and herpes zoster. This pain affects almost 1% of the world’s total population and is aggravated as a result of dysfunction, lesion, or transitory perturbation in the peripheral and central nervous system. Some other causes of neuropathic pain include trigeminal neuralgia, peripheral and entrapment neuropathy, brachial plexus avulsion pain, spinal cord injury pain, post-herpetic neuralgia, arachnoiditis, phantom limb pain, and post-stroke pain.
Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=32
The report presents a definitive analysis of market drivers, market restraints, and trends that will impact progression of the global anticonvulsants for neuropathic pain market until the end of 2025. The report charts the developmental growth map in the future by analyzing the past performance of the market.
The research report analyzes the global anticonvulsants for neuropathic pain market from a competitive viewpoint as well. The report finds out how innovations and product development will present growth opportunities to market players to serve niche patient areas. The analysis of changing competitive hierarchy is presented through graphs and pictorial representations. The report is compiled after collecting data from industry-centric databases and scrutinized using validated analytical tools.
Global Anticonvulsants for Neuropathic Pain Market: Drivers and Restraints
The increasing incidence of people with neuropathic pain is one of the major factors driving the anticonvulsants for neuropathic pain market. In addition, a high number of patients refractory to alternate treatment methods, increasing use of generic drugs compared to branded drugs, and a high rate of polypharmacy are some other factors driving the growth of this market.
Get a discount @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=32
The development of novel drug molecules for neuropathic drug indications is also propelling the growth of this market. This is because less than 50% of the patients respond to existing drugs that are available for neuropathic drug indications. Moreover, these drugs are associated with a number of side effects, particularly when administered systemically. Hence, new drug variants that can provide convincing action mechanism will be a game changer in the global neuropathic pain market.
Some of the newer anticonvulsant drugs for neuropathic pain include Depomed’s Gralise (gabapentin gastric-retention), which is available since 2011 and is a ‘once –daily’ formulation. XenoPort’s Horizant (gabapentin encarbil) was introduced in 2012 and is a “twice-daily’ formulation.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth researh of the market, we try to bring about game-changing success for our clients.
Head - Internet Marketing
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anticonvulsants for Neuropathic Pain Market: Industry Survey and Outlook 2025 here
News-ID: 696919 • Views: 174
More Releases from TMR Research
Global Private LTE Market Analysis by Market Key Player, Product Application & G …
Global Private LTE Market: Overview The global private LTE market likely to registers significant growth during the course of forecast period from the period between 2018 till 2028. Moreover, this network provides the better alternatives of the public networks on account of high operational efficiency, low cost deployment and improved business application in terms of security. The private LTE market also provide more capacity and coverage and has facility to modify
Crude Sulfate Turpentine Market 2025 Harting S.A., Arizona Chemical Company LLC, …
Global Crude Sulfate Turpentine Market: Snapshot The global market for crude sulfate turpentine is growing at a robust pace and is likely to witness significant growth in the coming years. The increasing use of crude sulfate turpentine in diverse applications is expected to encourage the growth of the global market in the coming years. In addition, the rising demand for high-value products for personal care, especially in developing economies is likely
Wood Vinegar Market 2017 Analysis, Growth, Vendors, Shares, Drivers, Challenges …
Global Wood Vinegar Market: Snapshot Pyroligneous acid, commonly known as wood vinegar, is created from wood and plant materials, using a process known as destructive distillation. The core ingredients of wood vinegar include acetone, methanol, and acetic acid, and was historically used to produce acetic acid on large scales. Currently, the scope of use of wood vinegar stretches across a large number of application segments. One of the more common uses
Meat Processing Equipment Market 2025 | Key Technology Inc., JBT Corporation, Ma …
Global Meat Processing Equipment Market: Snapshot Changing food preferences, lifestyles, tastes, and habits of the global population have bolstered the growth of the market for meat processing equipment. Developing economies such as China and India have been exhibiting enormous demand for meat over the last few decades. Industrialization, growing urbanization, Western influence on the food habits of Eastern consumers, and the growing disposable incomes of people have offset the growth of
More Releases for Neuropathic
Global Neuropathic Pain Market 2018 Analysis and Forecast to 2028
Neuropathic Pain Market 2018 Wiseguyreports.Com adds “Neuropathic Pain Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Report Details: This report provides in depth study of “Neuropathic Pain Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Neuropathic Pain Market report also provides an in-depth survey of key players in the market which is based on the various objectives
Neuropathic Pain Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H1 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape. Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases.
Neuropathic Pain Market to Exceed US$ 8.3 Bn in 2024
According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Neuropathic Pain: Anticonvulsants Drug Class Segment Projected to Witness the Highest Growth Through 2024’, the global neuropathic pain market was valued at US$ 5.2 Bn in 2015 and is estimated to reach a market valuation of US$ 5.4 Bn by 2016. The market is projected to expand at a CAGR of 5.6% during an eight-year forecast
Neuropathic Pain Market Predicted to Rise at 5.6% CAGR
The global neuropathic pain market report profiles some of the top players operating in the global neuropathic pain market such as Baxter Healthcare Corporation, Depomed, Inc., GlaxoSmithKline PLC, Biogen Idec, Pfizer, Inc., Sanofi S.A., Johnson & Johnson Services, Inc., Eli Lily and Company, and Bristol Myers Squibb. These companies are primarily focusing on producing improved drugs for the treatment of neuropathic pain to gain maximum share in the global neuropathic
Neuropathic Pain Market grows with rising geriatric population
Global Neuropathic Pain Market: Overview Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also
Neuropathic Pain Market: Trends, Opportunities and Forecasts 2026
Companies mentioned in the research report Some of the key companies currently operating in global neuropathic pain market are Pfizer Inc., Johnson & Johnson Services Inc., Depomed Inc., Bristol-Myers Squibb and Company, Sanofi S.A., Biogen Idec Inc., Eli Lily and Company, GlaxoSmithKline PLC, and Baxter Healthcare Corporation. Global Neuropathic Pain Market: Overview Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or